Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicine which was referred to the Minister of Health under the provisions of section 24 (5) of the Act and is set out in the Schedule hereto:
Schedule
Product: Vaxigrip vaccine
Active Ingredients: Influenza virus haemagglutin type A/Moscow/10/99 H3N2 - like strain 30Ág/mL
Influenza virus haemagglutin type A/New Caledonia/20/99 H1N1 - like strain 30Ág/mL
Influenza virus haemagglutin type B/Hong Kong/330/2001 - like strain 30Ág/mL
Dosage Form: Solution for injection
New Zealand Sponsor: CSL New Zealand Limited
Manufacturers: Aventis Pasteur SA, Marcy L'Etoile, France
Aventis Pasteur SA, Val-De-Reuil Cedex, France
Dated this 12th day of December 2003.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on the
6th day of July 2001).